ArticlePDF Available

A Novel Myotoxin from the Venom of Trimeresurus mucrosquamatus

Authors:

Abstract and Figures

A novel myotoxin, designated TMPB, was purified from the venom of Trimeresurus mucrosquamatus by Sephadex G-100 superfine gel chromatography and fast protein liquid chromatography (FPLC). The N-terminal sequence of 24 amino acid residues was determined by protein sequencer. The sequence similarities between TMPB and other two phospholipase A(2) (PLA2s) previously purified from the same venom were 41.7% and 54.2%, respectively, but TMPB showed no detectable PLA(2) hydrolytic activity. Its molecular weight was estimated to be 16 000 by reducing SDS-PAGE and isoelectric point was determined to be 9.2 by isoelectric focusing electrophoresis. TMPB exhibited strong myotoxicity and platelet aggregation inhibiting activity, and the two activities could all be inhibited by heparin.
Content may be subject to copyright.
ISSN 05829879
物化学与生物物理学报
A CTA BIOC HIM I CA et BIOP HYS ICA S IN ICA 1999 315483488 CN 311300Q
ReceivedF ebruary 11 1999 A cceptedAp ril 141999
Corresponding aut hor Tel868715194279 Fax 86871
5191823 emailx utr 163 net
A Novel Myotoxin from the Venom of Trimeresurus mucrosquamatus
XU T ianRui WANG WanYu M ENG Q ingXiong HUANG YuHui
LU Q iuM ing an d X IONG YuLiang
Kun mi ng Inst it ute of Zoology t he Chinese Academy of S ciences K unming 650223 Chi na
Abstract A novel myotoxin design ated T MPB w as purified f rom the v enom of Tri meresurus
mu crosquamatus by Sephadex G100 superfine gel chromatography and f ast protein liquid
chromatography FPLCT he Nterminal sequence of 24 amino acid residues was determined by protein
sequencer The sequence similarities bet ween T M P B and other t wo phospholipase A2PLA2spreviously
purified from the same venom w ere 41 7and 54 2 respectively but T MPB showed no detectable
PLA2hy drolyt ic a ctivit y Its molecular weight w as estimated to be 16 000 by reducing SDSPAGE and
isoelectric point w as deter mined to be 9 2 by isoelectric focusin g electrophoresis T MPB ex hibite d st ron g
my otoxi cit y and platelet agg reg ation in hibitin g activ ity and the two activities could all be inhibited by
heparin
Key Words  M yotoxin phospholipase A2platelet Tr imeresurus mu crosquamatus venom
M yot oxins proteins that induce skeletal muscle
necrosis are divided into two types1Type I
includes sm all basic polypeptides such as peptide c
2
and my otox in
3that were isolated from the venom
of ratt lesnakes Ty pe II includes larger proteins that
have t he primary structures of ph ospholipase A 2T he
PLA2myotoxins are the main compo nent of
myotoxins identified in snake venom f rom virtually
every family and genus examined4T he PLA 2
myotoxins are divided into three groups1Group I
includes the presynaptic neurotoxin s w ith PLA2
hydrolytic activity such as c roto x in
5group II
includes the nonneurotoxic P LA2s wi th P LA2
activity such as myo toxin I6an d a myotoxin from
Vipera russel li venom7g roup I I I includes
myotoxin PLA 2s w hich exhibit very low or no
detectable P LA2h yd roly tic a ct iv ity such as a
myotoxin f rom B oth rops n um m ifer venom8and
myotoxin II from Bothrops moojeni venom9
M yonecrosis is a common symptom of victim bit ten
by snakes of Trimeresurus genus t herefor e the
investigation of the myotoxins in Tr imeresu rus
m ucrosqua matus is helpful fo r the treatment of sn ake
bite
He parin is an impo rt ant r egu lato ry f actor t o
PLA2w hich bin ds to PLA 2noncovalently and can
affe ct t he hy droly tic activities10pharmacological
activities11of PLA 2Thus the ef fects of heparin on
a certain P LA2myotoxin should be examined
In snake venom t here are numerous proteins
w ith P LA2activity some of t hem affect platelet
agg regatio n
1214So i t is in teresting to ex amine
w hether and how a cert ain PLA2affects platelet
agg regatio nUp to date there is no r epo rt a bout
how heparin affects the platelet aggregation function
of P LA2In t his study we purified and partially
sequenced a basic my oto xin TM PBf rom the venom
of TMucrosquamatus and investigated its platelet
agg regatio n in hibitin g activi ty We also studied the
pha rma co lo gical effe ct s of heparin o n TM P B
1Materials and Methods
11Materials
The crude ly ophilized venom of T
m ucrosqu am at us w as obtained f rom Ku nming
In stitu te of Zoology th e Chinese Academy of
S cien ce K unming Ch ina The mice used to
investigate myo toxicity were Kunming species t he
platelets of J apanese big ear rabbits were used to
deter mine platelet agg reg ation T he Sephadex G100
superfine gel Resource S cation exchange column and
f ast p ro tein liquid c hroma togr aphy F PL C sy stem
were purchased from Pharm acia Pisc at aw ay N J
USATh e 476A protein sequencer came from
Ap plied B iosyste m In c Foster Ci ty CA US
AHeparin 10 20 kDand ADP were obtained
from Sigma Chemical Co S t Louis MO US
AAll o t her reagen ts used we re of a naly t ical
g rade
12Isolation
The Tmucrosquamatus venom 05 g w as
dissolved in 0 05 molL sodiu m phosphate buff er plus
01 molL sodium chlo ride pH 6 2and applied to
Sephadex G100 superfine column 3 cm 100 cm
equilibrated wit h the same buff er Elution w as
perfo rmed using equ ilibrating buffer at a f low rate of
12 5 ml per h our
The fractions containing myotoxicity f rom
Sephadex G10 0 colum n w ere pooled lyophilized and
dialyzed ag ainst 0 03 molL sodium phosphate buffer
pH 7 5 then applied to Resource S colum n 18
cm 20 cmin the FPLC syst em Elution w as done
w it h a linear gradien t of sodium chloride 01 mol
Lin th e same buffer at a flow rate of 8 ml per
minute
13Electrophoresis
Reducing sodium dodecyl sulfatepoly acrylam ide
gel electrophoresis SDSPAGEw as c ar ried out on
12 5gels according to the method of Laemmli15
Using t he Pharmacia PhastSystem isoelectric
focusing w as performed w ith a pH gradient from 3 to
10 according to the methods recommended by
PhastGe l IE F M edia
14Nterminal sequencing
U sin g Edm an degr ad at io n me thod T he N
termin us was sequenced by a 476A pro tein sequencer
from A pplied B iosystem Inc
15PLA2activity
The PLA2activi ty w as me asu red using sy nthetic
dipalmitoyl Lphosphatidylcholine as subst rate pH
75 at 37 as described by Liu et al14
Enzymatically released f atty acid w as tit rated w ith 4
mmolL NaOH The unit of enzyme activity w as
exp ressed as mol of f atty acid released min per mg
protein
16Myotoxicity
Twelve male mice 20 25 gw er e divided in
tw o gr ou ps In group A each mo use w as injected
w it h 40 g TMPB in 100 l saline into the left
femo ral muscles In group B control each mouse
w as in jected wit h 100 l saline Af ter 9 h
postinjection half of the mice were sacrificed and af ter
20 h the rest w ere all sacrificed T he femo ral muscles
w ere subsequently removed and fixed in Bouin s
solut ion dehydrated t hrough a series of et hanol of
different concentrations and finally embedded in w ax
Sections of t he muscles were stained wit h
hem atoxyline and eosin H&E
To investigate the in hibiting effects of heparin
six mice w ere each injected w ith 40 g TM PB 40
g heparin incubated in 100 l saline solutio n f o r 12
min at 3 7 T hen these mice w ere treated as
described above
17Platelet aggregation inhibiting activity
Platelet aggregation was measured by t he
turbidimetric meth od using w ashed platelets T he
machine used was a SH93 Intelligent Blood
Agg rega tion and C oagu la tion Te ster Shanghai
Biochemical Instrument F actory Shanghai China
In order to avoid the effects of thrombin in plasma
we p repared w ashed platelets by t he f ollowing
metho d Platelet rich plasma PRPw as obt ained by
centrif uging citrated rabbit blood at 200 gfo r 5 m in
and then P RP w as centrifuged at 900 gfor 10 min
The supernatant w as discarded and the platelets w ere
w ashed twice and resuspended in Ty rode solution
Platelet count w as adjusted to 300 000 l
The washed platelets 200 lwere incubated
w ith 1 0 l sample at 37 for 1 min ADP w ith final
concentration of 6 mmolL w as added to initiate
platelet agg regation and the aggregation w as
recorded fo r 5 mi n Sa mple 1 h eparin 04g
sam ple 2 saline solution sample 3 T MPB 04g
heparin 04gincubated in 10 l saline for 12
minsample 4 TM PB 04g
2Results
21Isolation and Electrophores is
As show n in Fig 1A Tmucrosquamat us
venom applied to a Sephadex G10 0 superfine colum n
revealed 7 peaks T he peak 6 possessing the most
poten t myotoxicity w as then applied to a Resource S
column in F PLC sy stem Fig 1B T he b ig g est
peak ex hibitin g my otoxi ci ty w as homo geneous on
bot h reducing SDSPAGE and isoelectric focusing
electrophoresis Th e molecu lar weigh t w as estim ated
to be 16 000 and the isoelect ric point w as estimated
to be 9 2see Fig 2
22The Nterminal sequence
The homogenous my otoxin w as applied to 476A
protein sequencer and t he Nterminal sequence of 24
amino acids was determined Comparing w ith t he
protein se quences in data base of Sw issProt and
NCBI w e fou nd th at th e Ntermin al sequen ce w as a
typical P LA2sequence and named the myotoxin
T M PB
The Nterminal sequence similarities between
T M PB and ot her tw o P LA2s previously purified from
the same venom were 41 7and 54 2
respectively14 16T he sequence similarities between
TM PB and ot her tw o my otoxins from the venom of
Trimeresurus genus were 45 8and 41 7
respectively17 18The sequen cing result and t he
comparison w ith o ther snake PLA2s from
Trimeresurus genus w ere show n in Table 1
484 
AC T A B IOCH IM ICA et BIO P HYSI CA S IN IC A Vol 31No 5
T able 1 Nt erminal amin o acid sequences o f T M PB and severa l P LA 2s from the venom of Tr imeresurus genus
PLA2source Nterm inal sequence Similarity
Tm ucrosq uamat us AN L L Q F R KM I K K MT G K E P I L S YA T Y 100
Tmucrosquamat us BS L I E L G KM I F Q E T G KN P VK N Y G L Y 41 7
Tm ucrosquama tus CN LWQ F E NM I M K V AK K S G I L S Y S A Y 542
Tflavoviri dis S L V Q LWK M I F Q E T G K EA AK N Y G L Y 45 8
Tgramineus S V I E L G KM I F Q E T G KN P A T S YG L Y 41 7
Th e iden tical amino acids we re show n in bold le tte rs a nd t he nonidentical amino acids w er e showe d in nor mal lett er sTm u crosquam atus A
TM P BTmucrosquamat us B
14Tm ucrosquam a tus C
16Tf lavovi rid is17Tg ram ineus18
Fig 1C hr omato graph y pa ttern s in purify ing T M PB
from the venom of Tri m eresuru s mucrosquamat us
AC hroma tog raphy of c rude venom o n a Sephadex G100
superfine gel column BChro mat ography of myotoxicity peak
f rom S ephadex G100 superfine gel column on a Resource S
cation exchang e colum n in F PLC system
23PLA2activity
TMPB showed no detectable PLA 2hy dro ly tic
activity
24Myotoxicity
M acroscopic observation show ed th at th e limbs
injected wi th T M PB were noticeably swollen and
turgid Hemorrhage and edema were very obvious
surrounding the site of injection at 9t h h our A t 20th
hour the affected tissues ap peared very dark and
hard and the hemorrhage w as evident u pon
dissection
Ligh t microscopy at 9th hour after T M PB
injection paraffin sections revealed an obvious local
intercellular edema most myofibrils sh ow ed a m ore
hyaline and homogenous pattern Fig 3B
comp ar ed w ith the con trol Fig 3A most of
myofibrils appeared to be in t he init ial stages of
degenera tio n A sign of inflamm ation w as seen as
neut rop hils arou nd h yaline my ofibr ils Fig 3B
At 20th hour af ter T M PB injection th e affected
myofibrils appeared an amorphous mass of
disorganized and disrupted myofibrils contained in
basal lami na and t here w as e x ten sive hemo rrh ag e in
fo rm o f ex tr avasated e ry th rocytes w ithin t he
connective t issue N eut rophil infilt ration was very
obvious Fig 3C Microscopic examination of t he
tissues injected w ith heparin treated TM PB for 20
hou r show ed essentia lly no rmal m yofi brils although a
few n ecrotic myofib rils were surrounded by
neutrophils and hemorrhage could be seen in the
connective tissue Fig 3D T his suggested
heparin could inhibit the myo toxicity of T M PB
Fig 2Reducing SDSPAG E and isoelectric f ocusing electro
phoresi s of T M P B
ASDSPAG E 1m arker 2TM P B sampleT he molecular w eight
w as estima ted to be 16 000 BIsoelectric fo cusing elect ropho resis1
ma rker 2T M P B sample The iso electric po int w as estimated to be 92
25Platelet aggregation inhibiting activity
When the samples were mixed wi th w ashed
platelets TM PB could reduce th e rate and ex tent of
platelet aggregation induced by ADP When treated
w ith heparin the in hibiting activity of TM PB was
markedly reduced To exclude the effects of heparin
on platelet agg rega tio n heparin was also used as a
485Sep 19 99 XU T ianRui et a l A N ovel M yot ox in f rom t he Ven om of Tr im eresu rus mucrosquamatus
Fig 3Light micrographs of mouse skeletal muscles
AS keletal muscles afte r injection of 100 l physiological solution fo r 20 h no rmal controlThe myo fib rils ap pe ared
norma l BS keletal mu scles a fter injection o f T MP B for 9 h T he myofibrils appeared a hyaline and homogeneous pat tern
lots of m yof ibrils w ere sur rounded by ne utro phils arrow heads a f ew myof ibrils w e re necrotic NIntercellular edema
wa s ve ry obv ious CSke letal muscles after i nje ction of T M P B f or 20 h Ne crotic my ofibr ilsNrevealed an am orphous
mass of disorg anized and disrupted my ofibrils contai ned in basal lam inaex ten sive hem orr hage Hand neut ro phils
arrowheadsalso sho wn in t his section DSkeletal muscles after injection of TM PB treated by he pari n f or 20 h
M yof ibrils a ppeared essent ially no rm altho ugh f ew necrotic myof ibrils w ere surr ounded by neut rophils headsand
h em orr hage Hcould be seen in t he tissues
Fig 4Effe cts of T M PB on ADPindu ced p latele t
ag gregation in rabbit w ashed platelets
1heparin con trol2saline contr ol3T M PB t reated by
heparin 4T M PB
control We found that heparin did no t effect platelet
agg reg at io n a t th is concent ratio n Fig 4
3Discussion
Chen et al19isolat ed a neuroto x ic PL A2
m ole cula r w eigh t 1 5 000f rom TMucrosqua
mat us venom It exhibited PLA2hydrolytic activity
and showed some myotoxicity TM P B molecular
weigh t 16 000 pI 9 2 however sh ow s no
detectable P LA2hyd rolytic activity and exhibited
strong myot oxicity We searched Medline S wiss
modeline Protein Data Bankand G ene Bankin
internet but w e f ound no protein sequence identical
t o T M PB So T M P B i s a novel my oto xin i sola ted
from TM ucrosquama tu s venom T he Nterminal
sequence similarities betw een TM PB and other four
PLA2s from the venom of Tr imeresu r us genu s are
41 7 54 2 45 8and 41 7
respectively14 161 8There are 5 identical amino acid
residues among TM PB and oth er four P LA2s f rom t he
venom of Trimeresuru s genus see Table 1T M PB
exhibit s no detectable P LA2hy droly tic a ct ivity so it
needs fur ther data to ascertain T MPB s PLA 2
486 
AC T A B IOCH IM ICA et BIO P HYSI CA S IN IC A Vol 31No 5
identity
From Fig 3B it is clear that most myofibrils
revealed a hyaline and homogeneous state and we
think t hat these myofibrils are in the stage betw een
hypercontracting stage and initial stage of disruption
The neutrophils around the degenerated myofibrils
suggest that neutrophils may play an important role in
myonecrosis
TMPB exhibits no detectable PLA2activity but
its myot oxicity and platelet agg regation inhibiting
activity are ob vious these suggest i ts myotoxicity and
platelet ag g reg at ion inhibiti ng activi ty are
independent of P LA2hy drolyt ic act iv it y
F urt hermo re the myotoxicity and platelet
aggreg ation inhibiting activity can all be inhibited by
heparin so we infer th at the myo toxicity site and
platelet aggregation inhibiting site of T M P B may be
the same or overlapping w ith each o ther
He parin is an impo rt ant r egu lato ry f actor t o
PLA2it binds to PLA2no nco valen tly and af fects the
hydrolytic activities and pharmacological activities of
PLA210 11There were tw o distinct opinions
howeverabout how heparin binds to P LA2Some
scientists proved t hat heparin interacted w ith t he N
termin us of P LA2the in terfacial r ecog nitio n siteand
prevented PLA2from binding t o substrates10w hile
o thers f ound that heparin bound to PLA2at
continuous st retches of basic amino acids near the C
termin us and formed an inactive acidbase
complex11Because heparin is sulfated
polysaccharides composed of repeating disaccharide
units its longi tudinal axis is long enough to cover the
Nterminus and Cterminus of PLA 2w e th ink t hat
heparin may bind PLA2both on Nterminus and C
termin usBo th Nterminus and Ctermin us are all
critical to pharmacological activities of P LA2411
therefore w e th ink t his may be a reason w hy heparin
is a powerful and multivalent inhibitor of TM PB
Acknowledgements W e g rate fully acknow ledge
Dr Zh ang Y M r Jin Y Wen P J Z hu S W
and Li D Sin our laboratory for t heir valuable
suggests and technique support s
References
1Joh n so n E K O w nby C L I solation of a m yoto xin f rom t he veno m
of Ag kist rodon con tortr i x lat icinctus b roadbanded copperhead
and pathogenesis of m yonecrosis induced by it in mice Toxicon
1993 31 243 255
2M aeda N Tamiya N Patt abhirama n T R Russell F E Some
chemical properties of the v enom o f t he rat tlesnake Crotal us
vi rid is hel leriTo xicon 1978 16 431 441
3Nedelkov D Bieber A L Cha racterization of t he two my oto xin
isomers f ro m the pr air ie rattlesnake Crotal us v iridis vir idi sby
capilla ry zone elect rophoresis and fluor escence quenching studies
Toxicon 1997 35 689 698
4Ow nby C L Colberg T R W hite S P I solatio n characteriza tion
and crystallization of a pho spholipase A 2my otoxin from t he v enom
of t he prairie rat tlesnake Crot alus v iridis viri dis Toxicon
1997 35 111 124
5Gopalak rishna kone P D empster D M H awgo od B J Elder H Y
Cellula r a nd mit ochondrial change s induced in the st ruct ure of
mur ine skelet al muscle by c rotox in a neuro tox ic phospholipase A2
complex To xicon 1984 22 85 98
6G ut ir rez J M O wnby C L O dell G V Iso lation o f a myo toxin
from Bothrops asper v enom Partial characterization a nd a ction on
skeletal m uscle Toxicon 1984 22 115 128
7G ow da V T S chmidt J M iddlebroo k J L Primary sequence
dete rminatio n of t he most basic my onecrotic phospho lipase A2from
the venom o f Vipera russel li Toxicon 1994 32 665 673
8Gutir rez J M Chaves FGenJ ALom onte B Cama cho Z
Schosinsky K M y onecrosis induced in mice by a basic myo toxin
isolated fr om the veno m of the snake Bot hrops n umm if er jumping
viperfrom Costa RicaToxicon 1989 27 735 745
9S oares A M Rodrigues V M H omsiBrandeburgo M I T oy ama
M H L ombardi F R Arni R K Giglio J R A rapid p rocedure for
the isolation o f t he Lys49 myot oxin I I f rom Both rops m oo jen i
caissacavenom Bio chem ical characterization crys tallizatio n
my oto xic a nd edemat ogenic activity Tox icon 1998 36503
514
10 Dicciann i M B L illyS taude rman M M clean L R
Balasubramaniam A Harm ony J A K Heparin prevents the
binding of phospholipa se A2to pho spholipid micellerIm por tance of
the aminoterm inus Biochemistr y 1 99 1 30 9090 9097
11Lomo nt e B M o reno E T arkow ski A H anson L A M ac carana
MN eutralizing int eractio n between heparins and myo tox in II a
lysine 49 pho spholipase A2fro m Bothrops asper snake v enom
Ide ntification of a heparinbinding a nd cytolytic t oxin region by the
use of synthetic peptides and mo lecular mo delingJ Biol Chem
1994 269 29867 29873
12Kini R M Ev ans H J Review art icle Eff ects of snake v enom
pro teins in bloo d plat elet s Toxicon 1990 28 1387 1422
13 Yang X Y Liu G F W ang Q C 杨小毅刘广芬晴川
Inhibit o ry effects of a neut ral phospho li pase A 2purified from
Vipera russelli sia mensis Smit hsnake venom o n rabbit platelet
aggr ega tionJHengyang M edica l Col lege衡阳医学院 学报
1992 20 247 250
14 Liu C S C hen J M C hang C H C hen S W T eng C M Tsai I
HThe amino acid sequence and prope rties of an edemainducing
Lys49 ph ospholipase A 2homo log from the venom of Trim eresurus
m ucrosquam atus Biochim Biop hys A cta 1991 1077362
370
15 Laemmli U K Cleavage of struct ural pr oteins duri ng assembly o f
the head of bacteriophage T 4N at ure 1970 227 680
16Tsai I H Lu P J Wang Y M H o C LLi aw L L M o lecular
cloning and characterization of a neur otoxic phospho lipase A2from
t he v enom o f Taiw an habu Tri meresuru s m u crosquam atus
Bioch em J 1995311 895 900
17 Nakai M N akashima K O gaw a T Shimohigashi YH att ori S
Cha ng C C O hno M Pu rification and p rima ry str ucure of a
my oto xic Lysine49 phospholipase A2wi th lo w lipolyt ic activit y
from Ti meresurus gramineus venom T ox icon 1995 33
1469 1478
18 Yoshizumi K L iu S Y M iyata T Sait o S O hno M Iw anaga S
K ihara H Pur ificatio n and amino acid sequence of basic prote in I
a lysine49 pho spholipase A2with low activi ty from the venom of
Trim eresur us f lavov iridi s habu snakeTo xicon 1990 28
42 54
19 Chen L N L iu C S Cha ng C C I solation and characterization o f a
toxic phospholipase A2fro m t he venom of t he T aiw an ha bu
Tr imeresurus m ucrosqu amat us Biotechnol App l B ioche m
1994 19P t 161 73
487Sep 19 99 XU T ianRui et a l A N ovel M yot ox in f rom t he Ven om of Tr im eresu rus mucrosquamatus
种新的烙铁头蛇毒肌肉毒素
徐天瑞 王婉 孟庆雄 黄玉辉 吕秋敏 熊郁良
中国科学院昆明动物研究所昆明 650223
摘要用分子筛和快速蛋白质液相色谱FP LC铁头Tr imeresur us m ucrosquam atu s蛇毒中分离了一个新的碱性肌肉
毒素命名为 TM P B 它的分子量为 16 000 等电点为 92用蛋白质序列仪测定了其 N24 个氨基酸残基T M PB
他两个从同种蛇毒中分离到的碱性磷酯酶 A2的同源性分别为 417542 TM P B 没有明显的磷酯酶 A2 解活性
它的肌肉毒性和血小板聚集抑制活性却极强其肌肉毒性和血小板聚集抑制活性可被肝素所抑制
关键词肌肉毒磷酯酶 A2血小板烙铁头
收稿日期1999021 1 接受日期19990414
联系人Tel 868715194279F ax 868715191823emailx utr 163 net
关于召开第二届纪念曹天钦院士国际蛋白质讨论会的通知
为纪念我国著名生物化学家曹天钦院士逝世五周年曹天钦学术基中国科学院上海生物化学研究所分子 生物学
家重点实验室决定于 2000 611 615 日在上海召开第二届国际蛋白质讨论会会议将邀请国内外有关蛋白质
究领域的著名专家 20 余人作专题讲演会议将分口头报告及贴报两部分 展示各 实验室的研 究成果 还将对 下世纪的分
生物学和蛋白质的研究进行瞻望和讨论议欢迎国内外有关同行参加现将有关事项通知如下
1会议时间2000 61115 11 日为报到日期
2会议注册费国外参加者美元250
美元 150
陪同者美元150
国内参加者人民币1000
人民币600
上注册费包括会议开幕式及闭幕式的宴请 会议
间伙食及会议资料等费用但不包括住宿
3会议即将印发第一轮通有兴 者可 与右 列同
联系
中国科学院上海生物化学研究所
龚祖埙研究员
上海市岳阳路 320 邮政编码200031
T elFax 8 62164746510
Emailgon gzx server shcnc accn
中国科学院上海生物化学研究所科研处
女士
上海市岳阳路 320 邮政编码200031
T elFax 8 62164376688
Emailhuaxu sunm shc ncac cn
作专题讲演的专家名单
Burg ess Tong Australia
Blu ndell T om UK
BonCassian F ra nce
Burg ess Tony Australia
Ca stellino F rancis USA
C hina
戚正武 China
Claude B alny F rance
DavieEarl USA
Ebashi S etsu ro J apan
Erodos Ervin USA
Fo ster Donald USA
F ritz Hans Germany
Heinri kso n Bob USA
K oide T akehiko J apan
李载平 China
梁栋材 China
梁宋平 China
Nak ajima Terum Japan
Roizm an Bernard USA
T ang Jo rdan USA
邹承鲁 China
T urk Vito S lovenia
Wan g Albert USA
Wan g Jerry H H K China
龚祖埙
488 
AC T A B IOCH IM ICA et BIO P HYSI CA S IN IC A Vol 31No 5
... 1 However, myositis in P. mucrosquamatus envenomation remains an under-recognized complication. 2 Although enzymes identified in the venom of P. mucrosquamatus were responsible for the tissue injuries in animal models, 3,4 our study finding is the first case of US-documented myositis in P. mucrosquamatus bite, who recovered well after specific antivenom administration, and no operation was performed. US could be considered as an important diagnostic adjunct for the snakebite management. ...
... In fact, variation in snake venom composition is a ubiquitous phenomenon at all taxonomic level [16]. Recent studies showed that the composition and some main components of phospholipase A2 [17] are different between the Trimeresurus mucrosquamatus venom from Hunan Province (in Chinese mainland) and Taiwan Province. Daltry et al. [18] also demonstrated a significant relationship between geographic variation in diet and geographic variation in venom composition might reflect natural selection for the greater efficiency in killing and/or digesting different prey types in different regions. ...
Article
Full-text available
Abstract The tuberose plants are gaining an importance in pharmaceutical and perfume industries because of their peculiar secondary metabolic reactions for the synthesis of various commercial valuable compounds. Although tuberose plants are having a limitation to grow in nursery in worm countries, like India, so that a tremendous application of plant tissue culture has been used for in vitro cultivation of such plants. In this present work, the influence of growth regulators on in vitro shoot formation and regeneration was studied in a tuberose plant Polianthes tuberosa L. Rhizome was used as explant to culture on solid Murashige and Skoog (MS) medium containing different concentrations of indol-3-acetic acid (IAA) and/or 6- benzylaminopurine (BAP). The presence of BAP (1.5mg/l) was showed higher explant regeneration and shoot differentiation frequency (2.2±1.2 shoots/explant), producing about three fold as compared to control. After regenerating this plant through tissue culture, the leaves of the same plant was used for plant chemicals analysis qualitatively, suggested the some of the metabolites were enhanced with more extent. Thus, this work presents an appropriate proportion of BAP and IAA will, perhaps, be helpful for regeneration and cultivation of this plant in small scale nursery.
... In fact, variation in snake venom composition is a ubiquitous phenomenon at all taxonomic level [16]. Recent studies showed that the composition and some main components of phospholipase A2 [17] are different between the Trimeresurus mucrosquamatus venom from Hunan Province (in Chinese mainland) and Taiwan Province. Daltry et al. [18] also demonstrated a significant relationship between geographic variation in diet and geographic variation in venom composition might reflect natural selection for the greater efficiency in killing and/or digesting different prey types in different regions. ...
Article
Full-text available
Snake venom contains a variety of chemicals including pharmacological and toxicological properties. Venom proteins that are enabling such pharmacological properties have not been understood in details yet. We extracted venoms from Indian cobra ( Naja naja ) and viper ( Vipera russelli ) and purified by ion-exchange chromatography with DEAE Sephadex A-25 column, followed by HPLC connected with GF-250 column. The highest purification peaks obtained for fraction numbers 3-6 of both snake venoms when elution buffer with 0.1-0.2M NaCl was used in ion- exchange chromatography. The purity and molecular mass of the eluted fractions have further analyzed and confirmed by HPLC and SDS-PAGE. These results reported that the purified proteins were low molecular masses ranged from 10-17kD, which resembled to phospholipase A2 of other snake venoms. The potential antibacterial activity of these purified proteins was found against gram negative bacteria like E.coli by agar diffusion assay using 20µl concentrations, suggested these venom proteins can be useful for some pharmacological applications. MALDI-TOF-MS studies will further be helpful to understand the molecular structure of these proteins in detail.
Article
OBJECTIVE To investigate the effect of Protobothrops mucrosquamatus venom (PMV) and its fractions on functions of the circulatory system in vitro in order to better understand its toxicity mechanism. METHODS PMV was isolated to three fractions FI, FII and FIII with a different molecular mass range by Sephadex G-75 gel filtration chromatography. Platelet rich plasma was adjusted to 3×1011 L-1 by platelet poor plasma. Platelet suspension was incubated with PMV and its fractions 0.03 g·L-1 for 5 min, respectively, and platelet aggregation was determined on an LBY-NJ4 aggregometer. PMV and its fractions 0.05 g·L-1 were preincubated with plasminogen 0.1 U·L-1 for 10 min before chromogenic substrate cleavage activity was measured by endpoint and enzyme kinetics determination. PMV and its fractions 1.0 g·L-1 were incubated with rat plasma for 5 or 30 min, and thrombin time (TT), activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrinogen (FIB) content were assayed. The microvascular endothelial cells were exposed to PMV and its fractions 10, 50 and 250 mg · L-1, respectively, for 24 h, while the morphological change was observed using an inverted phase contrast microscope, and the cell viability was determined by MTT method. PMV and its fractions were incubated with guinea pig red blood cell suspension in the presence or absence of lecithin for different time, and hemolysis was measured. RESULTS Compared with normal control, platelet aggregation rate was significantly increased by PMV and F I (>71 ku)((12.4±4.1)%, (61.0±5.8)% and (56.9±5.9)%] (P< 0.01). PMV and F II (18-37 ku) significantly hydrolyzed chromogenic substrate S-2251 (P<0.01). PMV and F I caused plasma coagulation. Compared with normal control, F II and FIII (<10 ku) remarkably prolonged TT, APTT and PT(P<0.01). Morphological observation revealed that PMV, F I and F II detached the adherent cells. Compared with normal control group, PMV, F I and F II inhibited cell viability, and the survival rate of the cells decreased to (56.8±3.6)%, (71.6±3.8)% and(58.2±5.5)%, respectively. PMV and FII slowly caused slight hemolysis in absence of lecithin. PMV and F II caused significant hemolysis in the presence of lecithin, and the hemolytic rate increased to (81.0±4.0)% and (81.0±1.0)%(P<0.01) in 0.5 min, respectively, compared with (17.7±1.0)% of the control group. CONCLUSION PMV possesses different activities that affect the functions of the circulatory system in vitro, and the fractions play different roles in toxicity mechanisms.
Article
An L-amino acid oxidase (TM-LAO) from the venom of Hunan Trimeresurus mucrosquamatus was purified to homogeneity by three steps including DEAE Sephadex A-50 ion-exchange chromatography, Sephadex G-75 gel filtration and Resource Q ion-exchange chromatography. TM-LAO is composed of two identical subunits with a molecular weight of 55 kD by SDS-polyacrylamide gel electrophoresis. The molecular weight was different with that of LAO purified from the same species distributed in Taiwan that was 70 kD. The 24 N-terminal amino acid sequence of TM-LAO is ADNKNPLEECFRETNYEEFLEIAR, which shares high similarity with other Viperid snake venom LAOs and has moderate similarity with Elapid snake venom LAOs. Further studies found that TM-LAO inhibited the growth of E. coli, S. aurues and B. dysenteriae. TM-LAO also showed cytotoxicity and platelet aggregation activity. All the biological activities were eliminated by catalase, a H(2)O(2) scavenger. It was shown that these biological effects were possibly due to the formation of H(2)O(2) produced by TM-LAO.
Article
R. M. Kini and H. J. Evans. Review article—Effects of snake venom proteins on blood platelets. Toxicon28, 1387–1422, 1990.—Snake venoms are complex mixtures which contain pharmacologically active polypeptides and proteins. Several snake venom constituents interfere in platelet aggregation, an important cellular process in thrombosis and hemostasis. These components range in size from small molecular weight polypeptides to high molecular weight proteins. Some of the proteins are enzymes, such as phospholipase A2, proteinases, nucleotidases, or l-amino acid oxidase, while others do not exhibit enzymatic activity. These components may initiate and/or inhibit platelet aggregation. Some venom factors induce platelet agglutination. This review deals with the physical characteristics of these venom factors, the mechanisms of their platelet effects, structure-function relationships, and their physiological significance.
Article
A myotoxin with phospholipase A2 (PLA2) activity was isolated from the venom of the prairie rattlesnake (Crotalus viridis viridis, CVV) by cation-exchange chromatography. The toxin contains 123 amino acids and has an estimated mol. wt of 14,000. It is basic, with a pI above 9. Comparison of the N-terminal 33 residues of this myotoxin with other PLA2 proteins from snake venoms showed that CVV myotoxin has highest homology (91%) to one isoform of the B component of crotoxin from Crotalus durissus terrificus venom, and less homology (73–75%) to mojave toxin from Crotalus scutulatus scutulatus venom and agkistrotoxin from Agkistrodon halys Pallas venom. It has the least homology (40–43%) to PLA2s from venom of two other snakes in the Crotalus genus which are neither neurotoxic nor myotoxic. CVV myotoxin induces the type of myonecrosis typical of snake venom myotoxins with the PLA2 structure, i.e. rapid disruption of the plasma membrane as indicated by the presence of delta lesions, hypercontraction and clumping of the myofilaments, and necrosis of affected skeletal muscle cells. Inhibition of the phospholipase activity of the toxin with p-bromophenacyl bromide inhibits the myotoxic activity, indicating that for some myotoxins with the PLA2 structure, the catalytic activity is important for myotoxic activity. This is the first report of the isolation of a non-neurotoxic, single-chain PLA2 myotoxin from the venom of a snake from the Crotalus genus.
Article
Following a single i.m. injection of a sublethal dose of crotoxin into the hindlimb of mice, degenerative changes were observed in the soleus muscle in the ensuing 72 hr using light and electron microscopy. A similar degree of myonecrosis resulted from the injection of the phospholipase A2 subunit alone, whereas crotoxin reconstituted from a chemically modified phospholipase A2 subunit with low catalytic activity showed weak myonecrosis and the non-enzymic subunit, crotapotin, was inactive. Visible defects of the sarcolemma were associated with underlying necrotic areas and attraction of macrophages. Internally, hypercontraction bands were often present and mitochondria in the rounded, orthodox configurational state contained linear dark bodies as part of their crystal organization. In fibre segments with slow onset of degeneration, many mitochondria additionally contained clusters of electron opaque deposit and in mitochondria, heavily laden with such deposits, energy-dispersive microprobe analysis showed the presence of high concentration of calcium. It was concluded that the primary site of action of crotoxin was hydrolysis of the sarcolemmal membrane and that mitochondrial changes were associated with calcium accumulation in response to an altered internal environment. Regeneration of fibres was rapid.
Article
The venom of the Southern Pacific Rattlesnake, Crotalus viridis helleri, was separated into three lethal and several non-lethal peaks by gel filtration. Peak I was a protein having a mol. wt of ca. 100,000 and an intravenous ld50 of 0.58 mg/kg. Peak II had a mol. wt of ca. 30,000 and a ld50 of 1·7 mg/kg. Peak III, the peptide, had a mol. wt of ca. 6000 and a ld50 of 1·96 mg/kg and moved as a cation on strip and polyacrylamide gel electrophoresis. On ion exchange chromatography the peptide was resolved into three lethal fractions. The major fraction, C, was a basic polypeptide containing 43 amino acid residues with six half cystine residues. Its mol. wt was 4990, as calculated from its sequence, 7600 as estimated from Sephadex G-50 gel filtration and 5200 by SDS- disc gel electrophoresis. The differences are being studied. Analysis showed the peptide contained almost 20% lysine. On sequencing, the most basic amino acid residues were distributed in the N-terminal and C-terminal parts. The middle part was rather hydrophobic.
Article
The activity of the major isoform of porcine pancreatic phospholipase A2 (PLA2), designated B-PLA2, against micellar substrates is inhibited by heparin. Inhibition is a consequence of binding of the enzyme to heparin, documented by a heparin-induced alteration in the intrinsic fluorescence of B-PLA2 and in the 8-anilino-1-naphthalene sulfonate fluorescence and by the enhanced rate of chemical modification of the active site residue His-48. As a consequence of heparin binding, the conformation of B-PLA2 at the active site and at the amino-terminus is altered, and the enzyme does not bind to phospholipid micelles. In spite of the heparin-induced conformational changes, B-PLA2 retains its ability to catalyze the hydrolysis of monomeric phospholipid. Other glycosaminoglycans can bind to and inhibit the activity of B-PLA2 toward organized phospholipids, but none tested is as effective as heparin. An isoform of the pancreatic enzyme, designated UB-PLA2 and which corresponds to iso-pig PLA2, does not bind to nor is its catalytic activity influenced by heparin. A peptide corresponding to the amino-terminal 26 residues of B-PLA2 can rescue PLA2 from heparin inhibition. A similar peptide corresponding to the amino-terminus of UB-PLA2 has no effect on heparin inhibition. A model for the inhibition of B-PLA2 by heparin is proposed in which the catalytically significant effect of heparin is to interact directly with the amino-terminus of B-PLA2, the interfacial recognition site, to prevent the enzyme from binding to micellar substrates.
Article
Three phospholipase A2 enzymes or homologs were purified from the venom of Trimeresurus mucrosquamatus (Taiwan habu). The most abundant one was found to be a phospholipase homolog without enzyme activity, and its complete amino acid sequence was determined using oligopeptide fragments derived from digestion by endopeptidases Glu-C, Asp-N, Lys-C and alpha-chymotrypsin, and by means of gas-phase sequencing. The sequence revealed that the protein belonged to the Lys-49 family of snake venom phospholipase A2. This protein's function was characterized as edema-inducing. The Lys-49 protein has the potential to bind membrane phospholipid and Ca2+ (Kd = 1.6 x 10(-4) M) as shown by ultraviolet difference spectra; however, the catalytic site appeared to be inactive and the edematous response was independent of the protein's hydrolytic activity. Mast cells and platelets were shown to be subject to activation by the Lys-49 protein.
Article
A basic protein (pI 10.2), named basic protein I, was purified to homogeneity from the venom of Trimeresurus flavoviridis (Habu snake) after four chromatographic steps. The amino acid sequence of this protein was determined by sequencing the S-pyridylethylated derivative of the protein and its peptides produced by chemical (cyanogen bromide and formic acid) and enzymatic (chymotrypsin, Achromobacter protease I, and Staphylococcus aureus V8 protease) cleavages. The protein consisted of 122 amino acid residues and was similar in sequence to phospholipases A2 from the venoms of crotalid and viperid snakes. A most striking feature of this protein is that aspartic acid at the 49th position common in phospholipases A2 is replaced by lysine. When the protein acted on 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphorylcholine, oleic acid was preferentially released, indicating that the protein has phospholipase A2 activity. Its molar activity toward 1,2-dilauroyl-sn-glycero-3-phosphorylcholine, however, was 1.5% that of T. flavoviridis phospholipase A2 isolated previously. The fact that both affinity to Ca2+ and reactivity to p-bromophenacyl bromide of basic protein I are approximately one order of magnitude lower than those of T. flavoviridis phospholipase A2 might explain the low activity of basic protein I.
Article
The mode of action of a basic myotoxin isolated from Bothrops nummifer venom was studied. This myotoxin is a basic polypeptide of 13,000 mol.wt, with a high content of lysine and aspartate, as well as of hydrophobic amino acids. It lacked phospholipase A2 activity when tested on several substrates at different pH values. Upon i.m. injection into mice, the toxin induced early morphological alterations typified by 'delta lesions' in the periphery of muscle fibers, an indication that the plasma membrane was the first cellular structure to be affected. Afterwards, necrotic cells had a clumped appearance, which then changed to a more hyaline histological pattern. Removal of necrotic material by phagocytes was followed by skeletal muscle regeneration, with the presence of myoblasts, myotubes and fully regenerated myofibers. The toxin induced a rapid and drastic drop in muscle creatine and creatine kinase contents of injected muscle, as well as an increase in serum levels of the enzymes lactic dehydrogenase and creatine kinase. Moreover, total muscle calcium increased significantly after toxin administration. Myotoxin induced a dose-dependent release of peroxidase entrapped in liposomes made from muscle phospholipids. The lack of phospholipase A2 activity in this toxin, together with the observation that it behaved as an amphiphilic protein in charge-shift electrophoresis, suggests that it might penetrate and disorganize muscle plasma membrane by means of a hydrophobic interaction.
Article
Using an improved method of gel electrophoresis, many hitherto unknown proteins have been found in bacteriophage T4 and some of these have been identified with specific gene products. Four major components of the head are cleaved during the process of assembly, apparently after the precursor proteins have assembled into some large intermediate structure.
Article
A myotoxic phospholipase has been isolated from Bothrops asper venom by ion-exchange chromatography on CM-Sephadex followed by gel filtration on Sephadex G-75. The toxin is a basic polypeptide with an estimated molecular weight of 10,700. It has both phospholipase A and indirect hemolytic activities, but is devoid of proteolytic, direct hemolytic and hemorrhagic effects. When injected i.m. into mice the toxin induces a rapid increase in plasma creatine kinase levels and a series of degenerative events in skeletal muscle which lead to myonecrosis. The toxin induces an increase in intracellular calcium levels and is able to hydrolyze muscle phospholipids in vivo. Pretreatment with the calcium antagonist verapamil failed to prevent the myotoxic activity. It is proposed that B. asper myotoxin causes cell injury by disrupting the integrity of skeletal muscle plasma membrane and that myotoxicity is at least partially due to the phospholipase A activity of the toxin.